INSTITUTION'S PROFILE
Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
Publications (1)
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review.
Journal: Expert opinion on pharmacotherapy
Publication date:
Journal: Expert opinion on pharmacotherapy
Publication Year: